• Acta paediatrica · Sep 2014

    Review

    Review finds insufficient evidence to support the routine use of heated, humidified high-flow nasal cannula use in neonates.

    • S Shetty and A Greenough.
    • Division of Asthma, Allergy and Lung Biology, MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London, London, UK.
    • Acta Paediatr. 2014 Sep 1;103(9):898-903.

    UnlabelledA literature review was carried out following concerns about the use of heated, humidified, high-flow nasal cannulae (HHFNC) in premature infants. Randomised trials following extubation showed that HHFNC was associated with similar or greater reintubation rates than nasal continuous positive airway pressure, but significantly better nasal trauma scores. Infections with Ralstonia bacteria were an issue.ConclusionThere is insufficient evidence to support the routine use of HHFNC for premature infants and further research is required.©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.